What this means
This study will look at whether frailty scores can predict complications and death better than standard tools. It will also compare heart procedures with medicine alone, but no results are posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 75 and over
- Where
- 1 site
The science
- Registered title
- Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome
- Trial ID
- NCT07366684 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- ST Elevation (STEMI) Myocardial Infarction, Non ST Elevation Myocardial Infarction (NSTEMI), Unstable Angina Pectoris
- What is tested
- Percutaneous Coronary Intervention (PCI), Conservative Medical Therapy
- Sponsor
- Clinical Center Niš
- Ages
- 75 Years to no maximum
- Dates
- First posted Jan 26, 2026 · updated May 15, 2026
Registry summary
This study will evaluate clinical characteristics, frailty, and predictors of prognosis in patients aged 75 years and older who are hospitalized with acute coronary syndrome (ACS). The research includes both a retrospective and a prospective cohort. The aim is to determine whether frailty scores, combined with clinical and laboratory parameters available at admission, can improve risk prediction for complications and mortality compared with standard risk scores (TIMI, GRACE, Syntax). The study will also compare outcomes between patients treated with percutaneous coronary intervention (PCI) and those treated conservatively with medications. Patients will be followed during hospitalization and for six months after discharge. The results are expected to contribute to more personalized treatment strategies for elderly patients with ACS.
Sites (1)
- Clinical Center Niš, Niš, Serbia